| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 203 companies in the Health Care Equipment & Supplies industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan 17, 2023 | MYO Myomo, Inc. | Henry David A72 | Chief Financial Officer | Buy | 76,923 | $0.33 | $24,999.98 | +88.8% | +64.6% | +831.6% | |
| Jan 17, 2023 | STIM Neuronetics, Inc. | Furlong Stephen74 | CFO | Sell | 16,050 | $6.13 | $98,386.50 | -4.1% | -64.8% | -51.4% | |
| Jan 17, 2023 | EW Edwards Lifesciences Corp | Chopra Daveen59 | Cvp, Tmtt | Sell | 4,000 | $78.00 | $312,000.00 | -17.5% | +6.6% | -6.4% | |
| Jan 17, 2023 | TMDX Transmedics Group, Inc. | Hassanein Waleed H56 | President &CEO | Sell | 7,500 | $64.14 | $481,050.00 | -1.8% | +8.0% | +22.0% | |
| Jan 17, 2023 | TMCI Treace Medical Concepts, Inc. | Mott Richard W81 | Director | Sell | 11,014 | $26.00 | $286,377.22 | -0.9% | -1.4% | -52.2% | |
| Jan 17, 2023 | TMDX Transmedics Group, Inc. | Gordon Stephen52 | Chief Financial Officer | Sell | 5,000 | $60.12 | $300,600.00 | -46.7% | +8.0% | +22.0% | |
| Jan 13, 2023 | NEOG Neogen Corp | Jones Douglas Edward48 | Chief Operating Officer | Buy | 2,500 | $17.91 | $44,775.00 | +26.7% | -6.8% | +1.8% | |
| Jan 13, 2023 | KIDS Orthopediatrics Corp | Odle Gregory A76 | Executive Vice President | Sell | 1,771 | $45.00 | $79,695.00 | -2.4% | +8.4% | -36.5% | |
| Jan 13, 2023 | TMDX Transmedics Group, Inc. | Khayal Tamer I53 | Chief Commercial Officer | Sell | 5,900 | $60.20 | $355,180.00 | -81.9% | +15.4% | +33.7% | |
| Jan 13, 2023 | EW Edwards Lifesciences Corp | Mussallem Michael A65 | Chairman &CEO | Sell | 19,875 | $78.09 | $1,552,124.21 | -11.2% | +8.1% | -5.5% | |
| Jan 13, 2023 | TMCI Treace Medical Concepts, Inc. | Mott Richard W81 | Director | Sell | 48,986 | $26.00 | $1,273,662.13 | -1.9% | -0.0% | -51.1% | |
| Jan 13, 2023 | AHCO Adapthealth Corp. | Everest Hill Group Inc.86 | 10% Owner | Sell | 350,201 | $20.03 | $7,014,221.00 | -1.3% | -44.0% | -68.1% | |
| Jan 13, 2023 | INSP Inspire Medical Systems, Inc. | Buchholz Richard73 | Chief Financial Officer | Sell | 12,500 | $250.03 | $3,125,359.31 | -13.4% | -3.9% | -27.7% | |
| Jan 13, 2023 | STIM Neuronetics, Inc. | Cannell Capital LLC69 | 10% Owner | Sell | 204,812 | $6.58 | $1,346,759.96 | -1.4% | -63.2% | -51.5% | |
| Jan 12, 2023 | TMCI Treace Medical Concepts, Inc. | Scanlan Sean F.65 | Chief Innovation Officer | Sell | 25,000 | $25.57 | $639,307.50 | -71.5% | +0.7% | -50.7% | |
| Jan 12, 2023 | TMCI Treace Medical Concepts, Inc. | Bays F Barry80 | Director | Sell | 55,255 | $25.31 | $1,398,504.99 | -1.3% | +0.7% | -50.7% | |
| Jan 11, 2023 | BLFS Biolife Solutions Inc | Schulz Marcus71 | Chief Revenue Officer | Sell | 258 | $21.94 | $5,660.52 | -0.5% | -13.1% | -23.1% | |
| Jan 11, 2023 | SYK Stryker Corp | Fink M Kathryn | VP, Chief Hr Officer | Sell | 10,107 | $258.50 | $2,612,668.84 | -12.1% | +12.3% | +19.4% | |
| Jan 10, 2023 | PACB Pacific Biosciences Of California, Inc. | Van Oene Mark79 | See Remarks | Sell | 26,722 | $9.53 | $254,767.55 | -4.0% | +12.1% | -18.5% | |
| Jan 10, 2023 | AHCO Adapthealth Corp. | Everest Hill Group Inc.86 | 10% Owner | Sell | 200,000 | $20.00 | $4,000,000.00 | -1.4% | -40.9% | -67.1% | |
| Jan 9, 2023 | KIDS Orthopediatrics Corp | Odle Gregory A76 | Executive Vice President | Sell | 229 | $45.04 | $10,315.01 | -0.3% | +8.3% | -32.4% | |
| Jan 9, 2023 | ATEC Alphatec Holdings, Inc. | Sponsel David61 | EVP, Sales | Sell | 10,000 | $11.99 | $119,900.00 | -1.8% | +33.5% | +23.7% | |
| Jan 9, 2023 | EW Edwards Lifesciences Corp | Bobo Donald E Jr64 | Cvp,Strategy/ Corp Development | Sell | 6,725 | $77.50 | $521,187.50 | -9.7% | +8.4% | -0.7% | |
| Jan 9, 2023 | LFWD Lifeward Ltd. | Lind Global Fund II LP51 | 10% Owner | Buy | 25,661 | $0.79 | $20,272.19 | +0.3% | -16.1% | +55.1% | |
| Jan 9, 2023 | CTKB Cytek Biosciences, Inc. | Jiang Wenbin75 | President And CEO | Sell | 20,000 | $10.66 | $213,200.00 | -0.3% | -15.0% | -20.1% |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.